The ultimate goal of the project is to evaluate the health beneficial effect of soybean-derived dietary bioactive compounds in reducing the occurrence of chronic metabolic diseases through an animal model. Chronic metabolic disease is one of the significant threats to the health of the US citizen. In our FY19 study, we have identified the alteration in the levels of metabolites and peptides after gastrointestinal digestion, during sprouting of soybean which potentially results into enhanced anti-inflammatory activity. Thus, the primary objective of this proposed project is to evaluate the effect of different bioactive compounds of germinated soybeans in exhibiting anti-inflammatory effect....
Updated February 12, 2021:
View uploaded report
The United Soybean Research Retention policy will display final reports with the project once completed but working files will be purged after three years. And financial information after seven years. All pertinent information is in the final report or if you want more information, please contact the project lead at your state soybean organization or principal investigator listed on the project.
